+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Healthcare Resource Utilization Among Commercially Insured Clobazam and Non-Clobazam-Treated Patients With Lennox-Gastaut Syndrome
Home
Publications
Healthcare Resource Utilization Among Commercially Insured Clobazam and Non-Clobazam-Treated Patients With Lennox-Gastaut Syndrome
Back Home
Healthcare Resource Utilization Among Commercially Insured Clobazam and Non-Clobazam-Treated Patients With Lennox-Gastaut Syndrome
2016 68th AAN Annual Meeting
Francois, C. | Ogbonnaya, A. | Lokhandwala, T. | Landsman, P. | Duhig, A. | Shen, V. |
Volume: , Issue: , Pages: ,
The website uses cookies.
Learn More
Ok
